Related Experiment Video
Updated: May 5, 2026
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
Breast Articles From 2023: Informing Practice Across the Continuum of Care
Tari A King1,2,3, Elizabeth A Mittendorf4,5,6
1Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. tking7@bwh.harvard.edu.
Abstract:
With new investigations and clinical trials in breast oncology reported every year, it is critical that surgeons be aware of advances and insights into the evolving care paradigms and treatments available to their patients. This article highlights five publications found to be particularly impactful this past year. These articles report on efforts to select the minimal effective dose of tamoxifen for prevention, to challenge the existing age-based screening guidelines as they relate to race and ethnicity, to refine axillary management treatment standards, to optimize systemic therapy in multidisciplinary care settings, and to reduce the burden of breast cancer-related lymphedema after treatment. Taken together, these efforts have an impact on all facets of the continuum of care from prevention and screening through treatment and survivorship.
Insights
This review highlights key 2023 breast cancer research, focusing on optimizing tamoxifen dosage, challenging screening guidelines for diverse populations, refining axillary management, improving systemic therapies, and reducing lymphedema. These advances impact breast cancer care from prevention to survivorship.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Cancer Research
Background:
- Annual breast oncology research necessitates awareness of evolving treatment paradigms for surgeons.
- Key advancements impact prevention, screening, treatment, and survivorship.
Purpose of the Study:
- To summarize impactful breast cancer research from the past year.
- To inform surgeons about critical updates in breast cancer care.
Main Methods:
- Review of five impactful publications in breast oncology.
- Analysis of research on tamoxifen dosing, screening guidelines, axillary management, systemic therapy, and lymphedema.
Main Results:
- Identified research on minimal effective tamoxifen dose for prevention.
- Highlighted studies challenging age-based screening disparities related to race and ethnicity.
- Summarized refined axillary management standards and optimized systemic therapies.
- Included findings on reducing breast cancer-related lymphedema.
Conclusions:
- Recent breast cancer research offers significant insights across the care continuum.
- These advancements are crucial for improving patient outcomes in breast oncology.
- Surgeons must stay informed on these evolving treatment and management strategies.
More Related Videos
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Related Concept Videos
01:28Current Trends in Nursing I
01:30Current Trends in Nursing II
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:27Nursing Clinical Information System
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
01:22Standards of Care I
01:19Standards of Care II